Why were the results of the Heart Outcomes Prevention Evaluation ( HOPE ) trial so astounding ? 
<br>
<br> The Heart Outcomes Prevention Evaluation ( HOPE ) study was important because it showed the benefits of ramipril - an angiotensin - converting enzyme ( ACE ) inhibitor - in <font color="red">patients_2</font> <font color="red">at_2</font> <font color="red">high_2</font> <font color="red">risk_2</font> <font color="red">for_2</font> <font color="red">cardiovascular_2</font> <font color="red">events_2</font> <font color="red">._2</font> Treatment with ramipril significantly reduced the rates of death , myocardial infarction , stroke , coronary revascularization , cardiac arrest and heart failure , as well as the risk of diabetes - related complications and of diabetes itself . The effects of therapy with vitamin E were also evaluated , but no statistical benefits were shown . The benefits of ACE inhibitor therapy that were observed were likely due to a variety of mechanisms , not just a reduction in blood pressure .